Abstract PurposeSeveral individual approaches were combined to fabricate a novel nanoparticulate drug delivery system to achieve targeting and anticancer effects in various malignant cancer cells. MethodsDoxorubicin was conjugated to Poly(lactic-co-glycolic acid) (PLGA), which was formulated into nanoparticle via solvent-diffusion method. The surface of the nanoparticles was subsequently linked with Poly(ethylene glycol) (PEG) and Arg-Gly-Asp (RGD) peptide to realize both passive and active targeting functions. The multifunctional nanoparticles were then tested against several malignant cancer cell lines. ResultsThe conjugation increased loading efficiency of doxorubicin to PLGA nanoparticles (the encapsulation efficiency was over 85%) and alleviated the drug burst release effect substantially. The drug was released from the polymeric matrix in a sustained release manner over a period of 12Â days. The resultant nanoparticles were spherically uniform and well-dispersed. The nanoparticle targeting ability was proven through strong affinity to various integrin-expressing cancer cells, and much less affinity to the low integrin expression cancer cells. The nanoparticles also showed high efficacy in inducing apoptosis in specific malignant cancer cell. ConclusionThe developed multifunctional nanoparticles hold potential to treat malignant integrin-expressing cancers.
nanoparticles       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

ethylene glycol               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ethylene_glycol       

encapsulation                 0.9999990442144073^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Capsule_(pharmacy)    

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

matrix                        0.9999999999704414^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Extracellular_matrix  

conjugation                   0.7790093812224871^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Conjugated_system     

sustained release             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Time_release_technology

RGD                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Recognition_sequence  

cancer cells                  0.980436056670036^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Cancer_cell           

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

affinity                      0.9962481661238713^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand_(biochemistry) 

cancers                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cancer                

efficacy                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Efficacy              

drug                          0.9322972927770805^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

doxorubicin                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Doxorubicin           

affinity                      0.9962481661238713^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Ligand_(biochemistry) 

polymeric                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Polymer               

malignant                     0.9999993708719036^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

cancer cells                  0.980436056670036^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Cancer_cell           

PEG                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Polyethylene_glycol   

malignant                     0.9999993708719036^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

drug                          0.9322972927770805^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

apoptosis                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Apoptosis             

malignant                     0.9999993708719036^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticulate               0.911742742241028^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/nanoparticle          

cancer                        0.6162864513372048^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

conjugated                    0.9568199714897204^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Conjugated_system     

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

cell                          0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_(biology)        

peptide                       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Peptide               

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

malignant                     0.9999993708719036^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

cancer                        0.6162864513372048^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cancer                

anticancer                    0.9999537846988318^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chemotherapy          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

Poly(lactic-co-glycolic acid) 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/PLGA                  

integrin                      0.8029394273221641^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cell_adhesion         

cancer cells                  0.980436056670036^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Cancer_cell           

cell lines                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cell_culture          

drug delivery system          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Route_of_administration

expression                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gene_expression       

